PF-05190457
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-05190457, covering 2011-07-06 to 2012-05-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients [Phase 1]